Viking Therapeutics (VKTX) Misses Q1 EPS by 35c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($1.37), $0.35 worse than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• ECB policymakers debating doubling banks' minimum reserve requirement to 2% from 1% - Reuters
• Hasbro (HAS) call put ratio 1 call to 1.9 puts as share price down 2.2%